Search results
How a leukemia diagnosis sparked this all-natural toothpaste
Rolling Out· 5 days agoWhen Lucky's son was diagnosed with leukemia in 2016, it was his time to create a toothpaste that...
Community leaders hosting fundraiser for 8-year-old leukemia patient
The Norman Transcript· 4 days agoJade Turner, an 8-year-old second-grade student at Wilson Elementary, is beginning a...
Community rallies around blind Yuba City teacher now battling leukemia
CBS News· 3 days agoMiranda Smith became a teacher after feeling inspired by her own teachers while growing up as a...
Trametinib shows promise for children with relapsed or refractory juvenile myelomonocytic leukemia
Medical Xpress· 3 days agoThe MEK inhibitor trametinib (Mekinist) was an effective treatment for pediatric patients with...
Donald Duck Turns 90. Here Are 10 Facts About Disney's Duck
Time via Yahoo News· 6 days agoNash retired from Disney in 1971, he often performed his duck voice for children who were in...
Gypsy Rose Blanchard Experimented With Her Sexuality in Prison: ‘Kissed More Girls’ Than Guys
Us Weekly via Yahoo News· 3 days agoGypsy Rose Blanchard is opening up about exploring her sexuality while serving time in prison for...
Anti-Sunscreen Movement Spreads On TikTok. Here Are Issues With This Trend
Forbes· 4 days agoVarious posts on TikTok and other social media platforms have been throwing shade on the use of...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 2 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
...of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the...
Benzinga· 8 hours agoNurix Therapeutics, Inc. NRIX, a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today ...
Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto
Morningstar· 2 days agoThe biotechnology company on Friday said the approval is aimed at adult and pediatric patients one month or older with CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic ...